Home » Topics » BioWorld Science

BioWorld Science
RSS

First patient dosed in global phase I study of TST-005

July 16, 2021

Serum HBD2 is a marker of chronic spontaneous urticaria

July 16, 2021

Positive topline data from phase Ib study of GLPG-3667 in psoriasis

July 16, 2021

GLPG-3970 shows clinical activity in early phase clinical trials

July 16, 2021

Blue Water Vaccines licenses novel VLP vaccine platform from Cincinnati Children's

July 16, 2021

FDA accepts IND application for phase I/II study of ExoFlo in ARDS

July 16, 2021

Serum miR-146a is elevated in patients with COVID-19

July 16, 2021

Nascent and Manhattan BioSolutions present preliminary data for BCG-based COVID-19 vaccine

July 16, 2021

Guangdong Feipeng Pharmaceutical presents anti-PD-1 antibodies

July 16, 2021

AbbVie, Calico Life Sciences patent PROTACs targeting PTPN1 and/or PTPN2

July 16, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...